Alkermes
ALKS
$24.30
Share price
0.93%
Change (1 day)
-16.74%
Change (1 year)
Categories
Alkermes (ALKS) - Cash on Hand
Cash on Hand as of December 2023 : $0.77 B
According to Alkermes's latest financial reports the company has $0.77 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Alkermes - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.77 B | 27.12% |
| 2022-12-31 | $0.60 B | 13.45% |
| 2021-12-31 | $0.53 B | -15.55% |
| 2020-12-31 | $0.63 B | 18.7% |
| 2019-12-31 | $0.53 B | -0.8% |
| 2018-12-31 | $0.53 B | 24.4% |
| 2017-12-31 | $0.43 B | -12.82% |
| 2016-12-31 | $0.49 B | -7.02% |
| 2015-12-31 | $0.53 B | -15.27% |
| 2014-12-31 | $0.63 B | |
| 2013-03-31 | $0.22 B | 16.23% |
| 2012-03-31 | $0.19 B | -5.4% |
| 2011-03-31 | $0.20 B | -28.45% |
| 2010-03-31 | $0.28 B | -13.06% |
| 2009-03-31 | $0.32 B | -5.17% |
| 2008-03-31 | $0.34 B | -2.92% |
| 2007-03-31 | $0.35 B | 17.99% |
| 2006-03-31 | $0.29 B | 47.1% |
| 2005-03-31 | $0.20 B | 40.73% |
| 2004-03-31 | $0.14 B | 5.76% |
| 2003-03-31 | $0.13 B | -10.67% |
| 2002-03-31 | $0.15 B | -40.24% |
| 2001-03-31 | $0.25 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 2,864.09% | 🇺🇸 USA |
 Novartis NVS | $13.96 B | 1,705.06% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 1,540.61% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 1,183.55% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $12.28 B | 1,487.61% | 🇺🇸 USA |
 AstraZeneca AZN | $5.86 B | 657.60% | 🇬🇧 UK |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $32.46 M | -95.80% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 317.07% | 🇮🇱 Israel |